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Individual aggregates of amyloid 
beta induce temporary calcium 
influx through the cell membrane 
of neuronal cells
Anna Drews1, Jennie Flint1,*, Nadia Shivji1,*, Peter Jönsson2, David Wirthensohn1, Erwin De 
Genst1, Cécile Vincke3, Serge Muyldermans3, Chris Dobson1 & David Klenerman1
Local delivery of amyloid beta oligomers from the tip of a nanopipette, controlled over the cell surface, 
has been used to deliver physiological picomolar oligomer concentrations to primary astrocytes or 
neurons. Calcium influx was observed when as few as 2000 oligomers were delivered to the cell surface. 
When the dosing of oligomers was stopped the intracellular calcium returned to basal levels or below. 
Calcium influx was prevented by the presence in the pipette of the extracellular chaperone clusterin, 
which is known to selectively bind oligomers, and by the presence a specific nanobody to amyloid beta. 
These data are consistent with individual oligomers larger than trimers inducing calcium entry as they 
cross the cell membrane, a result supported by imaging experiments in bilayers, and suggest that 
the initial molecular event that leads to neuronal damage does not involve any cellular receptors, in 
contrast to work performed at much higher oligomer concentrations.
A pathological hallmark of Alzheimer’s disease (AD) is the presence of extracellular plaques composed of amy-
loid beta fibrils in the hippocampus and neocortex of the brain1–3. Amyloid beta (Aβ ) is formed by proteolytic 
processing of the transmembrane amyloid precursor protein by beta and gamma secretase. It aggregates to form 
small oligomers which then self-assemble into protofibrils and fibrils which are deposited as plaques. There is 
significant evidence that the plaques themselves are not toxic; indeed, it appears that the true agents of toxicity 
are the small soluble oligomers4–7. Although Aβ has been implicated in Alzheimer’s disease since the early 1980s, 
the primary target for Aβ oligomers and the mechanism of their toxicity remain elusive and include specific bind-
ing to a range of cellular receptors as well as disruption to the cell membrane and formation of pores in the cell 
membrane8,9. This important question has not been addressed to date due to a number of factors. Firstly, there 
has been a lack of methods to reproducibly make and characterise Aβ oligomers and secondly, the experiments 
to probe interactions of these oligomers with cells are often performed at oligomer and monomer concentrations 
much higher than those that occur under physiological conditions. In addition many cellular responses in these 
experiments are observed in minutes or hours, including cell death, raising questions of why it takes decades to 
develop the disease.
Experiments have been previously performed directly using human cerebral spinal fluid (CSF) from 
Alzheimer’s patients, without any preparation steps. This has shown that the Aβ oligomers present can induce 
long-term potentiation deficit in brain slices which can be prevented by the addition of antibodies to Aβ 10. CSF 
from Alzheimer’s patients has also been shown to cause cell toxicity which can be prevented by addition of phys-
iological amounts of extracellular chaperones11, such as clusterin. Furthermore, more recently a sensitive ELISA 
based method has been developed to directly measure the Aβ oligomer concentration in CSF and used to show 
that this is approximately 0.5 pM in patients with Alzheimer’s disease12. Taken together these results suggest that 
low pM concentrations of Aβ oligomers are capable of inducing neuronal damage but there have been no reported 
studies of the damage mechanism at these low concentrations.
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We have also previously studied the effect of synthetic oligomers of Aβ 40 and Aβ 42 on primary neuronal cells, 
as a function of oligomer dose13. In this study we used fluorophore labelled peptide so that single molecule fluo-
rescence detection could be used to characterise the concentration and relative size of the oligomers used in these 
experiments. The oligomers ranged in size from dimers to 30mers, decaying exponentially with oligomer size, so 
that most of the oligomers were small oligomers less than 10mers. Our results show that it is possible to observe 
calcium oscillations in astrocytes, but not neurons, at oligomer concentrations down to 200 pM, a concentration 
100 fold higher concentration than the oligomer concentration in human CSF12. The calcium oscillations, which 
were due to extracellular calcium entering the cell, led to reactive oxygen species (ROS) production and then 
caspase 3 activation in both astrocytes and neurons. These data are consistent with previous studies that show that 
the first cell-type affected by Aβ oligomers are astrocytes14,15.
In this work we have used a nanopipette to locally deliver Aβ oligomers to astrocytes to control the location 
and number of oligomers applied to an individual cell in order to gain more detailed insights into the molecu-
lar basis of the oligomer induced calcium influx, and how it depends on the number of oligomers that the cell 
encounters. A schematic of the experiment is shown in Fig. 1. Our method is based on Scanning Ion Conductance 
Microscopy (SICM)16, where a change in pipette current provides a real-time feedback to allow a nanopipette to 
maintain a controlled distance over a cell17, and can easily be combined with fluorescence imaging. We have used 
the nanopipette for controlled voltage and pressure driven delivery of small molecules, proteins or antibodies to 
defined positions on a surface18.
We have previously measured and modelled the delivery of reagents from the nanopipette as a function of 
pipette size, distance from the surface and the applied voltage and pressure19. This model is used to estimate 
the number of Aβ oligomers delivered from the nanopipette. In this work only a region of about 1 μ m2 is dosed 
with oligomers from a pipette held 300 nm above the cell surface, so there is only a small distance that molecules 
need to diffuse across before encountering the cell surface. This significantly increases the local flux of oligomers 
reaching the cell surface compared to bath application, due to an oligomer depletion layer outside the cell surface 
in the latter case. The use of SICM, therefore, allows us to have a constant and defined dose of oligomers to the 
cell surface. This enables us to perform highly quantitative measurement of the effect of low concentrations of 
oligomers on calcium influx on neuronal cells.
Results
Characterisation of synthetic oligomers of Aβ42. We have previously shown that oligomers made using 
fluorophore labelled Aβ peptide are as cytotoxic to cells as the unlabelled peptide, while the presence of the 
fluorophores allows us to measure the concentration of oligomers present using single molecule fluorescence20. 
We firstly characterised the synthetic oligomers of Aβ 42 formed during an aggregation reaction using Alexa Fluor 
488 and HiLyte Fluor 647 labelled Aβ 42 at 500 nM monomer. In these experiments we directly count the number 
of oligomers present since they give rise to coincident bursts of fluorescence. We can also use the brightness 
of the coincident burst from the oligomers to estimate the oligomer size distribution. Aggregation for 5 hours, 
with shaking, resulted in the formation of approximately 3 nM ± 0.5 nM oligomers, with a size distribution from 
dimers to 20mers, as measured by single molecule confocal microscopy. We observed no change in oligomer size 
distribution with time during the aggregation. A representative size histogram, obtained using single molecule 
confocal fluorescence measurements, is shown in Fig. 2 after 6 hours aggregation.
We also used a new aggregate-specific method to characterise the Aβ oligomers. This method detects 
surface-adsorbed aggregates by use of the dye Thioflavin T (ThT), which fluoresces when bound to oligomers, 
combined with an ultra-sensitive total internal reflection fluorescence microscopy (TIRFM)21. The advantage of 
this approach was that monomers gave no signal. This method allowed us to count the number of oligomers pres-
ent and measure their relative brightness. Experiments were performed with HiLyte Fluor 647 Aβ 42 only, since 
the Alexa Fluor 488 fluorescence overlaps with the ThT fluorescence, and these samples were imaged using ThT 
Figure 1. Schematic of the SICM experiment to measure the calcium influx in astrocytes. 
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after dilution by a factor of 200 corresponding to an oligomer concentration of 15 pM. The results are shown in 
Fig. 2B. This provided a simpler method to ensure that Aβ oligomer preparations used in the dosing experiments 
were reproducible.
Astrocyte dosing experiments. We initially performed experiments on astrocytes since we had previously 
observed that oligomers induced calcium influx in astrocytes using bath application, and shown that astrocytes 
are the first cells that the oligomers damage20. Astrocytes from a mixed glial preparation were loaded with the 
calcium sensitive dye Fluo-4 and kept in Leibovitz’s 15 medium (L15) to investigate the calcium influx into the 
cells due to the application of Aβ 42 oligomers (Fig. 1). Solutions containing samples of different concentrations of 
oligomers and monomer, were locally delivered, via the SICM nanopipette, to the surface of individual astrocytes 
by application of a combination of pressure and voltage. In these experiments the pipette is controlled 300 nm 
above the cell surface and locally applies oligomers within an area of about 1 μ m2. Previous work has shown that 
the opening of pores in the cell membrane has no effect on the performance of the SICM22. We have developed 
a quantitative model for dosing from the nanopipette (see Supplementary materials). The calcium influx that 
resulted from oligomer dosing was recorded via an EMCCD camera (Fig. 3A–C and Supplementary Movie 1). 
Initial experiments showed that frequent Ca2+ oscillations were observed in addition to a steady rise in intracel-
lular calcium on application of Aβ 42 oligomers. 6-Methyl-2-(phenylethynyl)pyridine hydrochloride (MPEP), a 
specific metabotropic glutamate receptor 5 (mGlu5) blocker, was added to the bath to prevent these Ca2+ oscilla-
tions (see Supplementary materials). Control experiments showed there was no increase in intracellular calcium 
on addition of L15 medium alone from the pipette or just synthetic monomer (Supplementary Figures S1 and S2). 
Since the uptake of Fluo-4 varies between cells we normalised the calcium traces to the initial level of calcium at 
the start of the experiment, so we could directly compare the results from different cells.
Quantitative dosing experiments were then performed using the previously characterised standard solution of 
approximately 3 nM ± 0.5 nM Aβ 42 oligomers with approximately 500 nM Aβ 42 monomer (Fig. 4). This standard 
solution was made freshly each day and then diluted to obtain different oligomer concentrations in the nanopi-
pette. We have previously shown that the oligomers are stable for several hours at picomolar concentrations once 
formed. This allows us to have a defined concentration of oligomers in the pipette for dosing experiments, since 
there is no dissociation of the oligomers on dilution20. Using our model we can estimate the oligomer concentra-
tion at the cell surface. Under the conditions of the experiment the oligomer concentration on the cell surface, 
csurface, at the point under the centre of the pipette is 0.33c0, where c0 is the oligomer concentration in the pipette 
(see Supplementary materials). The oligomer concentration on the surface drops to 0.5csurface, at a radial distance 
of approximately 500 nm away from this centre point19. The average surface oligomer concentration in this area 
of 500 nm radius is 0.2c0, and this value will be quoted in the rest of the paper. When there are 30 pM oligomers 
in the pipette then we estimate that during the 10 minute experiment about 1250 oligomers were delivered to the 
cell surface, corresponding to 2 oligomers per second (see Supplementary materials for details). This means that it 
can be assumed that individual oligomers are interacting with the cell surface one by one during the experiment. 
The average oligomer surface concentration, in the area below the pipette, can similarly be estimated to be of the 
order of 5 pM. This concentration of oligomers is within an order of magnitude of the oligomer concentration to 
that estimated to be present in human CSF in patients with Alzheimer’s disease, 0.5 pM12, and gives a detectable 
but small increase in intracellular calcium.
The calcium influxes observed are complex since the cells can respond to the oligomer induced calcium influx 
over the 10 minute experiment and there was significant variation between the responses of different cells. We 
Figure 2. Characterisation of synthetic oligomers of Aβ42. (A) Oligomer size distribution after 6 hours 
aggregation measured using single molecule confocal microscopy. (B) Total internal reflection fluorescence 
microscopy image of oligomers on a glass surface, using Thioflavin T, and the corresponding brightness 
histogram of 27 field of views.
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analysed these data by firstly looking at the average behaviour of all the cells dosed at a specific oligomer concen-
tration at the cell surface. The averaged cellular response showed a steep increase in the beginning (first 100 sec-
onds) of the experiments, increasing with the oligomer concentration at the cell surface, and then the calcium 
level plateaus or is reduced at later times as the cell responds to the rise in intracellular calcium (Fig. 3). We 
then integrated the normalised calcium influx for each cell over the 10 minute experiment and averaged these 
together to compare the total amount of calcium entering the cell at a specific oligomer concentration at the cell 
surface (Fig. 4A). The total calcium entering the cell increases with oligomer concentration until at high oligomer 
concentrations the cell responds by reducing the intracellular calcium. Due to the fact that the cells respond to 
reduce oligomer induced calcium influx, the overall increase in total calcium is not proportional to the oligomer 
concentration, so that a 100 fold increase in oligomer surface concentration from 5 to 500 pM only doubles the 
total amount of calcium entering the cell. At low surface oligomer concentrations, 5 pM, there is still a statistically 
significant increase in the total amount of calcium over 10 minutes compared to the control (p-value of 0.0197). 
To confirm that the effects we observed are due to oligomers we performed dosing experiments in the pres-
ence or absence of clusterin, an extracellular chaperone that we have shown to preferentially bind oligomers13,23 
(Fig. 4B–D). No significant calcium influx was observed in the presence of clusterin confirming that Aβ 42  
oligomers are causing the influx.
To test whether cells were still able to recover after the application of Aβ 42 oligomers the pipette was removed 
after 5 minutes from the cell when dosing with a surface concentration of 1250 pM oligomers. The results were 
compared to experiments with application over the full 10 minutes. Figure 5 shows that astrocytes were indeed 
able to remove the excess calcium and recover back to basal levels. This suggests that any membrane disruption or 
pore formed by the oligomers is transient. If permanent pores were formed in the cell membrane then the calcium 
influx would be expected to continue to increase when dosing of oligomers was stopped.
Experiments on neurons. We next repeated these experiments on neurons at a surface oligomer concen-
tration of 500 and 1250 pM (Fig. 6 and Supplementary Figure S3). Neurons showed a similar response to astro-
cytes at 500 pM but a significantly smaller response at 1250 pM, due to the neurons responding to the dosed 
oligomers by reducing the intracellular calcium. These data suggest that Aβ 42 oligomers have similar effects on 
astrocytes and neurons but that the cells respond differently to the oligomer induced calcium influx and that 
neurons respond to reduce the intracellular calcium at a lower oligomer concentration.
Figure 3. Effect of dosing synthetic Aβ42 oligomers on intracellular calcium of astrocytes. (A–C) Representative 
data showing an astrocyte treated with an average surface concentration of 500 pM Aβ 42 oligomers. (A) At the start 
of the experiment, (B) after 5 min, (C) after 10 min. (D) The average change in the normalised intracellular calcium 
of astrocytes with Aβ 42 oligomer surface concentrations from 500 fM− 25 nM applied. Movies were taken over 
10 min. Images were taken every 400 msec to 1 sec (n is greater than 6 for each trace). For the negative control L15 
buffer only was dosed from the nanopipette and for the positive control 2 μ M Ionomycin was applied. The error bars, 
SEM, are shown every 50 seconds. The n value for each trace is tabulated in supplementary materials.
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Figure 4. Aβ42 oligomer dose dependency and the prevention of oligomer-induced calcium influx by 
clusterin. (A) Analysis of data in Fig. 3. Total integrated calcium entering an astrocyte as a function of oligomer 
concentration at the cell surface over the 10 minute experiment. There was a small reduction in integrated 
calcium in control cells, due to loss of dye and photobleaching over the 10 minute experiment. This was measured 
in control experiments and has been subtracted from all the data. Error bars are SEM. (B,C) Normalised calcium 
traces for an astrocyte with 500 pM oligomer concentration at the cell surface over the 10 minute experiment 
in the presence (n = 5), (B) and absence, (C) of 2 μ g/mL clusterin in the pipette (n = 5). The oligomers were 
incubated with clusterin for 15 minutes before dosing was started. (D) Total integrated calcium for the data in 
(B,C) corrected for photobleaching and dye loss. The p value was 0.016.
Figure 5. Recovery of astrocytes intracellular calcium after the application of Aβ42 oligomers. Cells 
were treated with an average surface concentration of 1250 pM Aβ 42 oligomers for 10 minutes in the control 
experiments or for the first 5 minutes and then observed for a further 5 minutes to determine if the cells 
recovered. The traces are the average of the response from several individual cells (n = 10 control, n = 3 
recovery). The error bars, SEM, are shown in both traces every 50 seconds.
www.nature.com/scientificreports/
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Figure 6. Comparison of the integrated change in intracellular calcium over 10 minutes between astrocytes 
(n = 6 and n = 14) and neurons (n = 3 and n = 7) at oligomer surface concentrations of either 500 or 
1250 pM respectively, corrected for photobleaching and dye loss. Error bars are SEM. The p values were 
0.9995 for the 500 pM data and 0.0281 for the 1250 pM data, using a two way ANOVA, showing that there is 
a significant difference in the oligomer dose response of astrocytes and neurons. The normalised intracellular 
calcium traces for neurons are shown in Supplementary Figure S3.
Figure 7. (A) Astrocytes were dosed with an average surface concentration of 500 pM Aβ 42 oligomers (n = 3) 
and showed calcium entry. (B) Astrocytes were dosed with an average surface concentration of 500 pM Aβ 42 
oligomers after pre-incubation with 150 nM Nb3, a nanobody to Aβ (n = 8). The concentration of oligomers 
during the pre-incubation is approximately 3 nM and monomer concentration is approximately 500 nM. 
Blocking of calcium entry was observed. (C) Astrocytes were dosed with an average surface concentration 
500 pM Aβ 42 oligomers after pre-incubation with 150 nM of an alpha synuclein specific nanobody, NbSyn87 
(n = 3). The oligomer concentration during the pre-incubation is approximately 3 nM and monomer 
concentration is approximately 500 nM. No blocking of calcium entry was observed. (D) Average integrated 
calcium in the presence and absence of the nanobody to Aβ , corrected for photobleaching and dye loss. Error 
bars are SEM. The p value was 0.0013.
www.nature.com/scientificreports/
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Inhibition of calcium influx with nanobodies. One advantage of our approach is that it can be used to 
test the effectiveness of antibodies or nanobodies that target Aβ at reducing oligomer induced calcium influx. We 
used a nanobody, Nb3, that binds to the epitope 17–28 of Aβ with a measured Kd for the monomer of 13 nM24. In 
these experiments we pre-incubated synthetic oligomers of Aβ 42 with 150 nM Nb3 for 15 minutes and then per-
formed nanopipette dosing experiments on astrocytes (Fig. 7). Our experiments show that Nb3 is very effective 
at blocking the calcium influx caused by Aβ 42 oligomers. This reduction in calcium influx was presumably due to 
nanobodies binding to the oligomers, reducing or preventing interaction with the cell membrane.
Bilayer experiments. To further investigate the molecular mechanism of cellular damage we performed 
experiments on model bilayers. Fluorescently labelled Aβ 42 was added to either a glass slide or to a supported 
lipid bilayer (SLB), using solutions prepared from the same stock solution, to further elucidate the mechanism by 
which Aβ inserts or crosses the cell membrane (Fig. 8A,B). An Aβ 42 monomer bath concentration of 2.5 nM with 
15 pM oligomers was used for the glass slide experiments, whereas a 100 times higher concentration was used 
for the SLB experiments, to compensate for Aβ 42 binding less readily to the SLB. Single molecules could easily be 
discerned in both cases and oligomers were distinguished from monomers on the basis of their intensity and the 
number of steps in their photobleaching profiles. A monomer bleaches with a single step while a dimer bleaches 
in two steps etc (Fig. 8C,D). Molecules with four or more bleaching steps approach an exponential bleaching 
profile and are here termed “tetramers or larger” oligomers (Fig. 8E).
The total amount of bound Aβ 42 on the glass slide was 1.4 times higher than on the SLB. For the glass sur-
face we counted 77 ± 3% monomers, 16 ± 3% dimers, 2 ± 1% trimers and 6 ± 2% tetramers or larger (mean 
value ± one standard deviation estimated from a binomial distribution of n = 174 molecules). These percentages 
are likely different from our confocal measurements in solution due to the tetramer or larger oligomers binding 
preferentially to the glass, as observed previously20. However, whereas only a smaller fraction of the molecules 
on the glass surface were tetramers or larger oligomers, we found that more than 90 ± 3% of the molecules on 
the lipid bilayer were tetramers or larger oligomers (mean value ± one standard deviation estimated from a bino-
mial distribution of n = 128 molecules). That the SLB has a higher fraction of tetramers or larger oligomers than 
glass is statistically significant based on a two-proportion z-test (p-value of 10−49). In fact, the actual number of 
tetramer or larger oligomers on the SLB is estimated to be close to 100% when the binding of Aβ 42 to defects in the 
lipid bilayer is taken into account. This was estimated by counting the number of monomers to trimers on the SLB 
at different concentrations of Aβ 42 in the bath solution. Aβ 42 was observed to bind more rapidly to glass than the 
SLB, so that the Aβ 42 will first bind to holes/defects in the SLB. Using photobleaching step analysis the numbers of 
monomers to trimers were found to remain approximately the same when the concentration was changed from 
2.5 nM to 250 nM (between 5% and 13% of the total numbers of molecules in the 250 nM sample), whereas the 
concentration of tetramer or larger oligomers increased monotonically with total protein concentration. Since 
there are two orders of magnitude less tetramer or larger oligomers than monomers in the bath solution, this also 
explains why a higher bath concentration of Aβ 42 is needed for the lipid bilayer experiments to get comparable 
numbers of bound molecules, as for the glass slide experiments. It should also be noted that the initial increase 
in intensity seen in Fig. 8E is not due to addition of Aβ 42 from solution since the bath solution was replaced with 
buffer solution without Aβ 42, but is a phenomenon we see for all tetramer or larger oligomers in the SLB. This 
is possibly due to photoisomerisation of Alexa-647 from dark states to a bright trans state, when excited by the 
laser25.
From the SLB experiments we could furthermore distinguish between whether the oligomers tend to (i) bind 
on top of the lipid bilayer or whether they (ii) insert or try to cross the SLB. In the former case we expect any 
bound Aβ 42 to be mobile since the lipids the Aβ 42 bind to are mobile. However, the majority of the bound Aβ 42 
molecules on the SLB do not change their position noticeably and also remain in the same position after the bulk 
solution is exchanged with buffer solution (see Fig. 8 and Supplementary Movie 2). This suggests that either the 
Aβ 42 inserts fully into the SLB, which happens on a timescale < 1 s based on the frame rate of these experiments, 
or tries to cross the lipid bilayer. If the Aβ 42 spans the entire SLB, or tries to cross it, then the close proximity to 
the glass support will make Aβ 42 stick to the surface. The majority of the tetramer or larger oligomers appear to 
fully insert into or try to cross the uncharged lipid bilayer in contrast to Aβ 42 monomers that did not significantly 
interact with the uncharged lipids.
Overall these data show that tetramers or larger oligomers can span or cross lipid bilayers, a result consistent 
with our previous observation that oligomers can enter cells at 4 °C26, indicating that no active process is required.
Discussion
We used SICM dosing in these experiments since we reasoned that more oligomers would reach the cell surface 
per second by local dosing via the pipette than by bath application, so that calcium influx should be observed at 
lower surface concentrations. The reason for this is due to a depletion layer of oligomers close to the cell surface in 
bath application, which is reduced when delivering via the pipette close above the cell surface. This was confirmed 
by our experiments. In the brain the area of interaction of CSF with the cell is increased by a factor of 10–100, 
compared to dosing with a pipette, and the gap between cells is only 10–20 nm27. Higher number of oligomers 
would therefor encounter a cell each second and more calcium influx would occur. However, an additional factor 
in the brain is that in the extracellular fluid there is already a significant concentration of extracellular chaperones 
that can bind to the oligomers and prevent calcium influx. If, for example, 90–99%, of the oligomers are seques-
tered, then the concentration of unsequestered oligomers is only 1–10% of the total oligomer concentration. The 
net result should be that the oligomer induced calcium influx experienced by a cell in the brain is within a factor 
of 1–10 of the influx experienced by a cell in our vitro experiments, using local application via a pipette. Therefore 
we are working in an experimental regime where we observed the initial effects of oligomers on neuronal cells. 
www.nature.com/scientificreports/
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An additional advantage of using SICM dosing is that only small volumes of solution are needed, 10 μ L, allowing 
the straightforward extension of these experiments to dosing with samples of human CSF from AD patients in 
future studies.
While previous work has suggested that the initial damage caused by Aβ oligomers occurs at astrocytes14,20,28 
not neurons, our work shows that calcium influx can occur at average concentrations of oligomers on the cell 
surface down to 5 pM, comparable to the concentration of oligomers reported in human CSF, and occurs in 
both neurons and astrocytes. However, there are still some significant differences between the two experiments. 
In this work we have blocked oscillations induced by mGlu5 in astrocytes, allowing us to detect the slow rise in 
calcium influx in both neurons and astrocytes. In addition, we have a much higher rate of encounter between the 
oligomers and the cell surface, using nanopipette dosing, which more closely represents the situation in the brain, 
so we can observe detectable changes at lower oligomer concentrations. Our work shows that the cell responds 
to the calcium influx so that there is an increase in the total amount of calcium entering the cell as the oligomer 
concentrations is increased, but that this is not linear with oligomer concentration. At a threshold intracellular 
calcium concentration the cell appears to respond to the calcium influx and reduce the intracellular calcium and 
this threshold is lower for neurons than astrocytes.
Our data are consistent with the calcium influx occurring as the individual oligomers cross the cell membrane, 
so that when dosing is stopped the calcium influx is stopped and the cells can reduce the calcium to basal levels. 
During dosing the rate of calcium entry is presumably faster than the rate at which the cell can remove calcium, 
leading to an overall increase but, when dosing stops, the cell can recover. It is also worth noting that the calcium 
influxes observed are small, corresponding to less than 10% of the full dynamic range of Fluo-4 when saturating 
amounts of calcium are used. Thus the oligomers induce a low level “calcium trickle” over 10 minutes rather 
than a rapid and large change in calcium, which would lead to rapid calcium removal by calcium pumps. This 
low level of calcium entry was not detectable in our previous experiments due to the calcium oscillations. In the 
Figure 8. Fluorescence microscopy images showing Aβ 42-Alexa 647 monomers and oligomers immobilised on  
(A) a glass surface and (B) a POPC (uncharged) lipid bilayer at four consecutive times. (C–D) Fluorescence 
intensity traces showing single and two-step photobleaching for two different Aβ 42-Alexa 647 molecules on  
the glass surface corresponding to an Aβ monomer (circle in A) and dimer (square in A), respectively.  
(E) Fluorescence intensity trace showing an exponential decay in the fluorescence signal from an Aβ 42-Alexa 
647 larger oligomeμ r in the lipid bilayer (circle in B).
www.nature.com/scientificreports/
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brain, where no mGlu5 blocker is present, we expect this low level oligomer induced calcium increase to occur 
in addition to calcium oscillations in astrocytes. This would result in oscillations of other coupled astrocytes 
over wider areas creating additional problems in calcium homeostasis. The longer term effect of these astrocyte 
oscillations, as shown in other work, could be transcriptional changes and remodelling of the calcium signalling 
tool-kit of astrocytes that is selective to different/certain brain regions, providing an explanation of why certain 
brain regions are more prone to damage in Alzheimer’s disease29. There has also been one experiment performed 
on Aβ oligomer induced blocking of long-term potentiation, which was prevented by the addition of a blocker 
of mGlu530, although much higher oligomer concentrations were used in these studies. This suggests that the 
oligomer induced calcium oscillations may play an important role in the development of Alzheimer’s disease and 
may significantly amplify the effect of individual oligomers on astrocytes.
The number of any specific receptors in the 1 μ m2 region of the cell membrane, dosed by the pipette, is small. 
The affinity of the oligomer for this receptors also needs to be in the picomolar range for any binding to occur 
when dosed with picomolar concentrations of oligomers. Furthermore, if the affinity of the oligomer for the 
receptors was in the picomolar range then the off-rate would be expected to be very slow. This is inconsistent with 
our finding that the cells can recover within 10 minutes. Therefore we conclude that the calcium influx is caused 
by individual oligomers crossing the cell membrane, without any interaction with a specific receptor. However 
based on our work we cannot totally discount the possibility of a specific interaction with a receptor occurring. 
Previous work also supports the conclusion that no receptor is involved. Oligomers of Aβ 42 are ThT active21, pre-
sumably due to their beta sheet structure, and hence have hydrophobic groups pointing into solution, which is 
why tetramers or larger oligomers cross the lipid bilayer in our experiment, and also why they will bind and cross 
the cell membrane. A previous study has found small oligomers bound to the cell membrane at near physiological 
concentrations of Aβ monomer31. Studies of the permeabilization of liposomes, at much higher concentrations of 
Aβ oligomers, also show that no interaction with any receptor is required for molecules to exit the liposome32,33.
Our experiments do not allow us to determine the physical mechanism by which calcium enters the cell from 
the external media. This could be due to local disruption of the cell membrane or calcium ion entering at the same 
time that the oligomer crosses through the cell membrane. As calcium ions enter the cell, there will also be leak-
age of ATP from the cell into solution by the same mechanism. ATP leakage has been observed in other experi-
ments at much higher acute oligomer concentrations34, and may affect neighbouring cells leading to the release 
of pro-inflammatory cytokines. The amount of calcium influx occurring as the oligomer crosses will potentially 
depend on the oligomer size. While our study cannot address this point, there has been a previous study on entry 
of Aβ oligomers into oocytes using fluorescence imaging to detect the calcium influx35. Oocytes have no calcium 
pumps, making the calcium entry easier to detect. These data were analysed as if the oligomers formed permanent 
pores in the cell membrane that opened and closed. In the light of our experiments these data can be reinterpreted 
as different oligomers entering the cell by crossing at certain regions of the cell membrane and the wide range of 
different open times observed can be explained by the different transit times of the oligomers through the cell 
membrane. These transit times were fitted by a double exponential function with time constants of 5 and 16 ms 
and estimated conductance of 0.4–4 picosiemens. A small fraction of the oligomers, presumably large oligomers, 
were found to take longer to cross the cell membrane and allow more calcium to enter the cell. This reinterpre-
tation of the data is consistent with our finding that only about 1 in 500 Aβ oligomers were capable of triggering 
astrocyte oscillations20, presumably due to inducing a larger calcium influx. This could be due to the oligomer size 
or the composition of the membrane to which the oligomer binds or a combination of these two effects.
It is widely recognised that altered calcium homeostasis is a key feature of Alzheimer’ disease. The fact that the 
calcium influx depends on the number of individual oligomers encountering the cell membrane means that the 
amount of disruption to calcium homeostasis that a cell will experience depends on the number of unsequestered 
oligomers in the CSF. Higher concentrations of oligomers or lower concentrations of extra-cellular chaperones 
will result in a larger disruption to calcium homeostasis in some neuronal cells, particularly astrocytes. This will 
ultimately lead to altered cell physiology and cell death and also adversely affect neighbouring neurons. This may 
explain why small increases in oligomer concentrations can be significant over long timespans. Furthermore, the 
effect of oligomer induced calcium influx in a fine structure, such as a synapse or fine protrusions, will be much 
more significant than at the cell body due to the smaller volume. This provides a possible explanation for the 
detrimental changes oligomers cause at the synapses of neurons at low concentrations, without the need for any 
specific interactions with any receptors.
Conclusions
We have developed a method to study the initial events that lead to cellular damage in Alzheimer’s disease. Our 
experiments suggest that as tetramers or larger oligomers cross the cell membrane of astrocytes or neurons, cal-
cium enters. This calcium influx can be prevented by clusterin and by a nanobody targeting the mid-region of Aβ . 
There appears to be no receptor involved in these initial events. The presence of low picomolar concentrations of 
Aβ aggregates therefore leads to continual low levels of calcium influx altering calcium homeostasis. An increase 
in the number of aggregates or reduction in the level of clusterin, which sequesters the aggregates, will lead to an 
increased rate of calcium influx and consequential cellular damage and, over time, earlier disease onset.
Material and Methods
Cell culture. Astrocytes were from a rat mixed glial preparation, cultured for 14 days in 75 cm2 flasks with 
Dulbecco’s Modified Eagle’s (DMEM) Medium (Invitrogen) supplemented with 10% fetal bovine serum, 1% 
Penicillin and Streptomycin and 1% L-Glutamine (Life Technologies) in a humidified atmosphere containing 
5% CO2 at 37 °C. Cells were passaged 2–3 times a week. For experiments the astrocytes were cultured to 40–70% 
confluence in 35 mm culture dishes with 14 mm glass microwell, number 1 thickness cover glass (MatTek). 
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Experiments were performed 1–5 days after plating. Cells were loaded with 2.3 μ M Fluo-4 AM (Life Technologies) 
for 10–15 minutes and washed twice with L15 (Life Technologies) afterwards.
Aβ42 aggregation. HiLyte Fluor 647 Aβ 42 (Cambridge Bioscience LDT) was purified on a Biosep SEC-s2000 
size exclusion column (Phenomenex) using pH 7.4 SSPE (0.01 M Na2HPO4, 0.15 M NaCl, 1 mM EDTA) as the 
running buffer. The peptide was kept in ice prior to purification, flash frozen immediately after and stored at 
−80 °C. For the cell experiments, the purified Aβ 42 was diluted to 500 nM in PBS and left shaking at 37 °C, 
200 rpm for 5 hours. It was centrifuged at 14,500 g for 10 minutes and then diluted to the required concentration 
in L15 medium. Clusterin was a gift of Professor Mark Wilson at the University of Wollongong and prepared 
using published proceedures36. The clusterin was used at with 2 μ g/mL.
Aβ nanobody. The Aβ specific nanobody Nb3 was isolated from a llama (Llama glama) immunized with Aβ40 
and by the construction and selection of a phage-display library containing the VHH genes, amplified from the 
peripheral blood lymphocytes, as described previously37. The Nb3 gene was subsequently recloned in a modified 
pHEN vector (pHEN6) containing a sequence coding for six consecutive histidine residues at the C-terminus of 
the nanobody and the nanobody was subsequently expressed in the periplasm of Escherichia coli and purified 
using immobilized metal affinity chromatography and size-exclusion chromatography, according to published 
protocols38. The concentration of Nb3 was measured by UV absorbance spectroscopy using a molecular extinc-
tion coefficient, which was calculated based on the sequence of the protein at 280 nM of 21,555 M−1 cm−1. The Kd 
of Nb3 for monomeric Aβ 40 has previously been measured as 13 nM using a Biacore 3000 24.
Synuclein nanobody. The α -synuclein specific nanobody, NbSyn87, was previously isolated by phage dis-
play selection following the immunization of a llama (Llama glama) with the A53T variant of the protein human 
α -synuclein39. The nanobody was subsequently recloned in a pHEN6 vector, expressed and purified according to 
an identical protocol as described above for the expression and purification of Nb3. The protein concentration of 
NbSyn87 was estimated by UV absorbance spectroscopy using a molecular extinction coefficient, calculated from 
the sequence of the protein, at 280 nm of 26,025 M−1 cm−1.
Single molecule confocal set-up. The same set-up and method was used to determine the oligomer con-
centration as previously described20,23.
ThT imaging. The protein was aggregated as described above. ThT (Sigma-Aldrich) stock solution was 
prepared in DMSO (Sigma-Aldrich) at a concentration of approximately 1 M and diluted into pre-filtered PBS 
(0.02 μ m filter, Whatman) to a final concentration of ~100 μ M. The final concentration was determined from 
the absorbance at 412 nm with an extinction coefficient of 36,000 M−1 cm−1. The stock solution was prepared 
freshly and filtered (0.02 μ m filter, Whatman) on a daily basis. Borosilicate glass coverslips (VWR International) 
were cleaned in an argon ion plasma for 1 hour and prepared for coating with a 20 mm × 20 mm Frame-Seal 
slide chamber (Bio-rad). The coverslips were coated with Poly-(L)-Lysine (PLK) (Sigma-Aldrich) for at least one 
hour. The PLK-coated surfaces were washed three times with PBS before the sample was applied. Aggregated 
Aβ 42 was used at a total monomer concentration of 1.25 nM in PBS with 5 μ M ThT. Each sample was left on the 
coverslip for 10 minutes prior to imaging to ensure binding of the aggregates to the surface. The imaging was 
then performed with 5 μ M ThT in PBS. The samples were imaged using a home-built total internal reflection 
fluorescence (TIRF) microscope limiting the detectable fluorescence signal to within 200 nm from the coverslip. 
A 405 nm Laser (LBX-LD, Oxxius Laser Box) was aligned and directed parallel to the optical axis at the edge of 
a TIRF objective (APON60XO TIRF, Olympus) mounted on an inverted Olympus IX-73 microscope for ThT 
imaging. Fluorescence was collected by the same objective, separated from the returning TIRF beam by a dichroic 
(Di01-405/488/532/635, Semrock), and passed through an appropriate filter (BLP01-488R-25, Laser 2000). The 
images were recorded on an EMCCD camera (Evolve 512 Delta, Photometrics) operating in frame transfer mode 
(EMGain of 4.4 e−/ADU and 250 ADU/photon). Each pixel was 207 nm. The distance between the 9 images 
measured in each grid was set to 350 μ m, and was automated (bean-shell script, Micromanager) to prevent user 
bias. Images were recorded continuously for 100 frames with 50 ms exposure in the blue channel (ThT emission) 
with 405 nm illumination.. Images were recorded at 50 ms exposure with 100 frames for each field of view in the 
blue channel (ThT emission). Data analysis was done using custom written procedures using the GDCS SMLM 
plugin (Sussex University) for ImageJ (http://imagej.nih./goc/ij). Briefly, the image stacks were averaged over the 
full set and the background was removed and the 2D Gaussian point-spread-functions (PSF) were fitted using 
PeakFit. The photon values for the histogram were calculated using EMGain from the extracted intensities.
SICM set-up. The SICM was built on an inverted Nikon Eclipse Ti-U. The microscope objective (Nikon, Plan 
Apo VC Water immersion × 60, MRD07601) was mounted in a piezoelectric drive (P-726, Physik Instrumente, 
UK) for this purpose, while the sample and nanopipette were positioned by XY (P-733.2DD) and Z (P-753) pie-
zos, respectively. All piezos were controlled via a computer using an Ionscope controller.
Nanopipettes were fabricated using a Sutter Instrument Co. model P-2000 laser-based puller, pulling 10 cm 
length, 1 mm/0.50 mm outer/inner diameter fire-polished borosilicate glass capillaries with filaments (Sutter, via 
Intracel UK Ltd.) using the program Heat 350, Fil 3, Vel 30, Del 220, Pul, Heat 390, Fil 3, Vel 40, Del 180, Pul 
255. The pull time range is 4.5–5.5 s. Typical nanopipette ion currents were 500 ± 1.5 pA pA for a 200 mV elec-
trode bias. Calcium influx was monitored using an epifluorescence set-up using 488 nM laser excitation and an 
EMCCD camera (iXon DU 897, Andor) for detection.
Calcium imaging experiments. For these experiments cells were kept in L15 (Life Technologies) con-
taining 1.26 mM Ca2+. 300 μ M 2-Methyl-6-(phenylethynyl)pyridine (MPEP) (Sigma Aldrich), with a specific 
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metabotropic glutamate receptor 5 (mGlu5) blocker, was added to the bath to prevent calcium oscillations. 
The pipette contained L15 (Life Technologies) plus different concentrations of Aβ 42 oligomers, with a total 
volume of 10 μ L. 2 μ M Ionomycin (Sigma Aldrich) added to the L15 for the positive control experiments. The 
computer-controlled nanopipette, mounted to the z-piezo, was positioned 300 nm above the cell. This distance 
was chosen by experience. It was far enough away to avoid mechanical stress to the cell, by activating mechano-
sensitive ion channels, and close enough to apply sufficient concentration to the cell. The pipette was kept in 
position using distance feedback control. Aβ 42 was released from the pipette by applying − 200 mV and 15 kPa 
pressure to the pipette. We chose a negative voltage because of the fact that HiLyte 647 has a slight negative charge. 
After the pipette was in place over the cell, calcium imaging was started and pressure applied to start delivery. The 
maximum observed fluorescence signals were about one order of magnitude smaller than the full dynamic range 
of Fluo-4 and are thus expected to be linearly proportional to Ca2+ flux. The data was normalised to the initial 
calcium fluorescence level, Δ F/Fo, to take account of variation in Fluo-4 loading between cells. The normalised 
calcium traces were analysed using OriginPro 2015.
Bilayer experiments. The SLB consisted of 1 palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
(POPC) lipids from Avanti Polar Lipids with 0.01 wt% of the fluorescently labelled lipid Oregon Green® 488 
1,2-Dihexadecanoyl-sn-Glycero-3-Phosphoethanolamine (Oregon Green® 488 DHPE; Invitrogen, UK) to visu-
alize the SLB in order to make sure there were no defects. After forming the SLB, Aβ labelled with HiLyte 647 was 
added to the dish. This was done at different concentrations (higher concentration leads to more binding), all in 
L15 media (from 2.5 nM to 250 nM). The binding of the Aβ was imaged with TIRF microscopy (with a HeNe laser 
operating at 633 nM) either with Aβ in the solution (at 1 s between frames) or after rinsing the solution to remove 
unbound Aβ (stream acquisition with 100 ms exposure time to measure single-step photobleaching).
Statistical analysis. Analyses of differences between two groups were conducted using a standard unpaired 
Student’s t test. For the data in Fig. 6 a two way ANOVA test (Sidak’s multiple comparison test) was performed.
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